The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines (PCV10 and PCV13) on Immunogenicity and Vaccine-serotype Carriage in Kenyan Infants
Phase of Trial: Phase IV
Latest Information Update: 16 Aug 2019
Price : $35 *
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms FPCV
- 14 Aug 2019 Status changed from not yet recruiting to recruiting.
- 27 Feb 2019 Planned initiation date changed from 1 Jan 2019 to 30 Mar 2019.
- 29 Nov 2018 New trial record